Sort
48,018 grants matching “immunotherapy”
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$527,354Albert Folch · University Of Washington · R01 · FY2023 · CA
An innate immune checkpoint in cancer immunotherapy
$527,107Carla Rothlin · Yale University · R01 · FY2020 · CA
Mechanisms of Hepatitis C Virus Evolution
$527,079Stuart C Ray · Johns Hopkins University · R01 · FY2011 · DA
Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.
$527,065Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA
PHASE I/II TRIAL OF HOKT3(1(ALA-ALA) IN TYPE 1 DIABETES
$526,914Columbia University Health Sciences · R01 · FY2004 · DK
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$526,891Albert Folch · University Of Washington · R01 · FY2022 · CA
Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer
$526,882Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Matrix assembly and remodeling during S. aureus biofilm development
$526,823Kenneth W. Bayles · University Of Nebraska Medical Center · P01 · FY2016 · AI
Sustaining Tissue Resident Memory T cells
$526,754Yina Hsing Huang · Dartmouth College · R01 · FY2023 · CA
TARGETING DEUBIQUITINASE USP10 TO POTENTIATE IMMUNOTHERAPY IN LUNG CANCER
$526,738Wayne State University · · FY2022 · Defense Health Agency
Harnessing the thymus for long-term tumor control with hematopoietic stem cell-derived naive CAR T cells
$526,721Johannes Zakrzewski · Hackensack University Medical Center · R37 · FY2024 · CA
High-Specificity Imaging Agents for Aggressive Prostate Cancer
$526,681Martin G Pomper · Johns Hopkins University · R01 · FY2016 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
$526,521Anna Karolina Palucka · Baylor Research Institute · R01 · FY2008 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$526,519Minah Kim · Columbia University Health Sciences · R37 · FY2025 · CA
[18F]4FN PET Imaging of Innate Immunity Activation During Immunotherapy-Induced Adverse Events
$526,490David R Piwnica-Worms · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Project 2
$526,318Paolo Provenzano · University Of Minnesota · P01 · FY2024 · CA
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$526,134Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$526,134Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
$526,128Abraham Ari Hakimi · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$526,078Edgar G. Engleman · Stanford University · R01 · FY2021 · CA
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
$526,030Andrea Facciabene · University Of Pennsylvania · R01 · FY2020 · CA
Tumor-penetrating nano-theranostics for image-guided interventions in spontaneous feline head and neck cancer
$525,840Yuanpei Li · University Of California At Davis · R01 · FY2020 · DE
RNA-Binding Proteins as Molecular Integrators that Control the Response of HGSOC to Ant-Cancer Therapies
$525,766Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2023 · CA